Iridex (IRIX) EBT (2016 - 2025)
Historic EBT for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to -$1.6 million.
- Iridex's EBT rose 1811.06% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year increase of 5442.99%. This contributed to the annual value of -$8.8 million for FY2024, which is 859.09% up from last year.
- Per Iridex's latest filing, its EBT stood at -$1.6 million for Q3 2025, which was up 1811.06% from -$973000.0 recorded in Q2 2025.
- Iridex's 5-year EBT high stood at $1.4 million for Q3 2021, and its period low was -$3.4 million during Q1 2024.
- In the last 5 years, Iridex's EBT had a median value of -$1.9 million in 2024 and averaged -$1.7 million.
- In the last 5 years, Iridex's EBT surged by 15048.65% in 2021 and then crashed by 25874.38% in 2022.
- Quarter analysis of 5 years shows Iridex's EBT stood at -$2.2 million in 2021, then soared by 44.55% to -$1.2 million in 2022, then plummeted by 158.61% to -$3.1 million in 2023, then soared by 72.84% to -$840000.0 in 2024, then plummeted by 86.79% to -$1.6 million in 2025.
- Its last three reported values are -$1.6 million in Q3 2025, -$973000.0 for Q2 2025, and -$1.7 million during Q1 2025.